← Eichor
Condition: Chemotherapy Side Effects Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chemotherapy Side Effects

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025
Phase N/A · 1 location(s) · Bernardino Clavo, MD, PhD · NCT05417737
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer
NA · 2 location(s) · Massachusetts General Hospital · NCT02290834
Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).
Phase 2/Phase 3 · 1 location(s) · Bernardino Clavo, MD, PhD · NCT06799351
Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer
NA · 1 location(s) · Fred Hutchinson Cancer Center · NCT05874297
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With B
Phase 2/Phase 3 · 61 location(s) · AbbVie · NCT06236438
Fibrosis in Chronic and Delayed Myocardial Infarction
Phase N/A · 1 location(s) · University of Edinburgh · NCT05756608
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients
Phase 3 · 12 location(s) · Sun Yat-sen University · NCT03907826
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06283927
Cardioprotection on Chemotherapy-Induced Cardiotoxicity
Phase 3 · 2 location(s) · Ain Shams University · NCT06853951
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
Phase 1/Phase 2 · 1 location(s) · University of California, Irvine · NCT04520139
A Study of Shengbai Oral Formula to Assess Safety and Alleviation of Adverse Effects in Cancer Patients Undergoing Chemo
NA · 1 location(s) · Sutter Health · NCT06706752
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT03589729
Remote Physical Activity Programming to Improve Outcomes in Cancer Survivors With and Without Type 2 Diabetes
NA · 1 location(s) · University of Oklahoma · NCT06725953
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
Phase N/A · 1 location(s) · University Hospital, Caen · NCT07191730
Antrodia Cinnamomea Extract Effects on Lung Cancer Patients' Quality of Life During Chemotherapy
NA · 1 location(s) · Tri-Service General Hospital (TSGH) · NCT07241182
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
Phase 1 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07319364
Effect of Cryotherapy in the Prevention of Madarosis Produced by Chemotherapy in Breast Cancer Patients
NA · 2 location(s) · University of Salamanca · NCT06955702
Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05775419
To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer
NA · 1 location(s) · GenMont Biotech Incorporation · NCT06039644
Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Seconda
Phase N/A · 1 location(s) · Bernardino Clavo, MD, PhD · NCT06816095
JUMP Prevalence of Sarcopenia and Chemobrain in Post-cancer Patients
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT05800535
Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Sa
NA · 1 location(s) · Institut de Cancérologie de Lorraine · NCT05936034
Taste Alterations Study
NA · 1 location(s) · Wake Forest University Health Sciences · NCT06669416
Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer
Phase 2 · 4 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06274879
Improve Cancer-related Cognitive Impairment
NA · 1 location(s) · University of Alabama at Birmingham · NCT05864274
Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in
NA · 1 location(s) · Azienda Sanitaria Locale di Asti · NCT07524829
Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients
NA · 1 location(s) · Erasmus Medical Center · NCT06622954
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Phase 2 · 67 location(s) · Eli Lilly and Company · NCT07169851
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
NA · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06536881
Effect of Vitamin D Supplementation on Chemotherapy Side Effects After Adjuvant Chemotherapy for Breast Cancer
NA · 2 location(s) · Jiuda Zhao · NCT06642441
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.